331 related articles for article (PubMed ID: 10680700)
41. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis.
Núñez-López R; Escribano L; Schernthaner GH; Prados A; Rodríguez-González R; Díaz-Agustín B; López A; Hauswirth A; Valent P; Almeida J; Bravo P; Orfao A
Br J Haematol; 2003 Jan; 120(2):257-65. PubMed ID: 12542483
[TBL] [Abstract][Full Text] [Related]
42. Expression of complement-regulatory proteins in normal and UW-preserved human liver.
Scoazec JY; Delautier D; Moreau A; Durand F; Degott C; Benhamou JP; Belghiti J; Feldmann G
Gastroenterology; 1994 Aug; 107(2):505-16. PubMed ID: 7518785
[TBL] [Abstract][Full Text] [Related]
43. Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease.
Mishra N; Mohata M; Narang R; Lakshmy R; Hazarika A; Pandey RM; Das N; Luthra K
Front Immunol; 2019; 10():2072. PubMed ID: 31555286
[TBL] [Abstract][Full Text] [Related]
44. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
[TBL] [Abstract][Full Text] [Related]
45. Altered expression of membrane inhibitors of complement in human gastric epithelium during Helicobacter-associated gastritis.
Sasaki M; Joh T; Tada T; Okada N; Yokoyama Y; Itoh M
Histopathology; 1998 Dec; 33(6):554-60. PubMed ID: 9870151
[TBL] [Abstract][Full Text] [Related]
46. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
Hourcade D; Liszewski MK; Krych-Goldberg M; Atkinson JP
Immunopharmacology; 2000 Aug; 49(1-2):103-16. PubMed ID: 10904110
[TBL] [Abstract][Full Text] [Related]
47. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
48. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.
Cosio FG; Shibata T; Rovin BH; Birmingham DJ
Kidney Int; 1994 Oct; 46(4):986-92. PubMed ID: 7532249
[TBL] [Abstract][Full Text] [Related]
49. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
50. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
51. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
52. Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy.
Imrie HJ; McGonigle TP; Liu DT; Jones DR
J Reprod Immunol; 1996 Oct; 31(3):221-7. PubMed ID: 8905554
[TBL] [Abstract][Full Text] [Related]
53. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
Fodor WL; Rollins SA; Guilmette ER; Setter E; Squinto SP
J Immunol; 1995 Nov; 155(9):4135-8. PubMed ID: 7594566
[TBL] [Abstract][Full Text] [Related]
54. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer.
Inoue H; Mizuno M; Uesu T; Ueki T; Tsuji T
Acta Med Okayama; 1994 Oct; 48(5):271-7. PubMed ID: 7532345
[TBL] [Abstract][Full Text] [Related]
55. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
56. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
[TBL] [Abstract][Full Text] [Related]
57. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
Seya T; Okada M; Hara T; Matsumoto M; Miyagawa S; Oshimura M
Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716
[TBL] [Abstract][Full Text] [Related]
58. Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor.
Rambaldi A; Terao M; Bettoni S; Tini ML; Bassan R; Barbui T; Garattini E
Blood; 1990 Dec; 76(12):2565-71. PubMed ID: 1702329
[TBL] [Abstract][Full Text] [Related]
59. Expression of complement regulating factors in gastric cancer cells.
Inoue T; Yamakawa M; Takahashi T
Mol Pathol; 2002 Jun; 55(3):193-9. PubMed ID: 12032231
[TBL] [Abstract][Full Text] [Related]
60. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
Fujioka S; Yamada T
Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
